BLINATUMOMAB FOR THE TREATMENT OF RELAPSED/REFRACTORY B-ACUTE LYMPHOBLASTIC LEUKEMIA: REPORT FROM A SINGLE CENTER

被引：0
|
作者：
Giammarco, S. [1 ]
Chiusolo, P. [2 ]
Metafuni, E. [1 ]
Sora, F. [2 ]
Laurenti, L. [2 ]
Innocenti, I. [1 ]
Autore, F. [1 ]
Bacigalupo, A. [2 ]
Sica, S. [2 ]
机构：
[1] IRCCS, Fdn Policlin Univ A Gemelli, Rome, Italy
[2] Univ Cattolica Sacro Cuore, IRCCS, Milan, Italy
来源：
HAEMATOLOGICA | 2019年 / 104卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PU12
引用
收藏
页码：158 / 159
页数：2
相关论文
共 50 条
  • [1] Blinatumomab for the Treatment of Relapsed/refractory B-acute Lymphoblastic Leukemia: Report from a Single Center
    Giammarco, Sabrina
    Chiusolo, Patrizia
    Metafuni, Elisabetta
    Sora, Federica
    Laurenti, Luca
    Innocenti, Idanna
    Autore, Francesco
    Bacigalupo, Andrea
    Sica, Simona
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 576 - 577
  • [2] Clinical utilization of blinatumomab and inotuzumab immunotherapy in children with relapsed or refractory B-acute lymphoblastic leukemia
    Contreras, Cristina F.
    Higham, Christine S.
    Behnert, Astrid
    Kim, Kailyn
    Stieglitz, Elliot
    Tasian, Sarah K.
    PEDIATRIC BLOOD & CANCER, 2021, 68 (01)
  • [3] Importance of blinatumomab in relapsed or refractory acute lymphoblastic leukemia B
    Machet, Antoine
    Gallego-Hernanz, Pilar
    Torregrosa-Diaz, Jose
    Leleu, Xavier
    HEMATOLOGIE, 2016, 22 (01): : 17 - 18
  • [4] Blinatumomab for Relapsed/Refractory Acute Lymphocytic Leukemia: A Single Center Experience
    Lin, Tara L.
    Mahmoudjafari, Zahra
    Aljitawi, Omar S.
    Singh, Anurag K.
    Shune, Leyla
    Ganguly, Siddhartha
    Abhyankar, Sunil
    McGuirk, Joseph
    BLOOD, 2015, 126 (23)
  • [5] Cannibalism in Relapsed B-acute Lymphoblastic Leukemia
    P. S. Shobhanaa
    Naveen Kakkar
    Indian Journal of Hematology and Blood Transfusion, 2018, 34 : 544 - 545
  • [6] Cannibalism in Relapsed B-acute Lymphoblastic Leukemia
    Shobhanaa, P. S.
    Kakkar, Naveen
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2018, 34 (03) : 544 - 545
  • [7] Profile of blinatumomab and its potential in the treatment of relapsed/refractory acute lymphoblastic leukemia
    Ribera, Josep-Maria
    Ferrer, Albert
    Ribera, Jordi
    Genesca, Eulalia
    ONCOTARGETS AND THERAPY, 2015, 8 : 1567 - 1574
  • [8] The role of blinatumomab in patients with relapsed/refractory acute lymphoblastic leukemia
    Benjamin, Jonathan E.
    Stein, Anthony S.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2016, 7 (03) : 142 - 156
  • [9] The Usefulness of Blinatumomab for Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia: A Review
    Watakabe, Mai
    Arakawa, Yuki
    Irikura, Tomoya
    Honda, Mamoru
    Mitani, Yuichi
    Oshima, Koichi
    Watanabe, Atsuko
    Mori, Makiko
    Fukuoka, Kohei
    Koh, Katsuyoshi
    PEDIATRIC BLOOD & CANCER, 2021, 68
  • [10] A Single Center Experience of Blinatumomab in 27 Pediatric Patients with Heavily Pretreated Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia
    Queudeville, M.
    Lenz, T.
    Doering, M.
    Holzer, U.
    Heinz, A.
    Teltschik, H. M.
    Kreyenberg, H.
    von Stackelberg, A.
    Schrappe, M.
    Feuchtinger, T.
    Schlegel, P.
    Lang, P.
    Handgretinger, R.
    Ebinger, M.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S153 - S153
12345